Nuri Ozturk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nuri Ozturk has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Aziz Sancar
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
15 shared publications Christopher P. Selby
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States
7 shared publications- Ibrahim Halil Kavakli
Department of Molecular Biology and Genetics, Koc University, Istanbul, Turkiye; Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkiye
6 shared publications Rui Ye
Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States
6 shared publicationsDongping Zhong
The §Departments of Physics, Chemistry, and Biochemistry, Ohio State University, Columbus, Ohio 43210
5 shared publications- Mehmet Ozturk
Department of Medical Biology Izmir Tinaztepe University School of Medicine Turkey
5 shared publications
Latest Publications
- Open Access
Single-component optogenetic control enables human portrait formation in cells
Continued exploration of novel photoreceptors is essential for advancing optogenetic tools, as differences in their reaction mechanisms and spectral sensitivity could enhance the versatility of available systems. While circadian clock photoreceptors represent promising candidates, only Arabidopsis Cryptochrome 2 (AtCRY2) has been widely adopted in current applications. Notably, both the light-dependent interaction of AtCRY2 with the CIB1 protein and its homodimerization have been exploited for diverse optogenetic applications. In our search for alternative circadian photoreceptors for optogenetic control, we aimed to develop a system functioning without the co-expression of interacting partners. In this context, Drosophila Cryptochrome (DmCRY) was a promising candidate due to its well-characterized photoreceptor function and defined light-dependent reaction mechanism. Upon illumination, DmCRY undergoes a conformational change that enables interactions with Jetlag and Timeless proteins, facilitating circadian clock resetting. DmCRY is also targeted for degradation via ubiquitylation by Jetlag and/or BRWD3, ensuring resetting occurs only once each morning. Notably, DmCRY is susceptible to light-induced degradation even when expressed in mammalian cells. Leveraging this property, we fused the Tet repressor (TetR) to the C-terminus of DmCRY to enable light-dependent regulation of gene expression via TetR-responsive elements. We demonstrate that this system modulates expression of Cas9 for gene knockout, dCas9 for transcriptional regulation, and recombinant proteins. Furthermore, using these tools with a photomasking technique, we generated human portrait images from cultured cells. These findings highlight DmCRY as a versatile optogenetic tool capable of controlling cellular processes with standard visible light, with potential for novel optogenetic platforms.
Open AccessSingle-component optogenetic control enables human portrait formation in cells
Continued exploration of novel photoreceptors is essential for advancing optogenetic tools, as differences in their reaction mechanisms and spectral sensitivity could enhance the versatility of available systems. While circadian clock photoreceptors represent promising candidates, only Arabidopsis Cryptochrome 2 (AtCRY2) has been widely adopted in current applications. Notably, both the light-dependent interaction of AtCRY2 with the CIB1 protein and its homodimerization have been exploited for diverse optogenetic applications. In our search for alternative circadian photoreceptors for optogenetic control, we aimed to develop a system functioning without the co-expression of interacting partners. In this context, Drosophila Cryptochrome (DmCRY) was a promising candidate due to its well-characterized photoreceptor function and defined light-dependent reaction mechanism. Upon illumination, DmCRY undergoes a conformational change that enables interactions with Jetlag and Timeless proteins, facilitating circadian clock resetting. DmCRY is also targeted for degradation via ubiquitylation by Jetlag and/or BRWD3, ensuring resetting occurs only once each morning. Notably, DmCRY is susceptible to light-induced degradation even when expressed in mammalian cells. Leveraging this property, we fused the Tet repressor (TetR) to the C-terminus of DmCRY to enable light-dependent regulation of gene expression via TetR-responsive elements. We demonstrate that this system modulates expression of Cas9 for gene knockout, dCas9 for transcriptional regulation, and recombinant proteins. Furthermore, using these tools with a photomasking technique, we generated human portrait images from cultured cells. These findings highlight DmCRY as a versatile optogenetic tool capable of controlling cellular processes with standard visible light, with potential for novel optogenetic platforms.
- 12 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (5) , 2061-2077
Design, synthesis and in vitro evaluations of new cyclotriphosphazenes as safe drug candidates
Although it is possible to discover new drug candidate molecules using in silico approaches, chemical synthesis followed by screening of their functions is still at the center of bioactive molecule discovery. While determining the potential effects of compounds on target signaling molecules or pathways, assessing their effects on the circadian rhythm is also very important for determining the efficacy of drug candidates because they control most of the signaling pathways. Herein, new members of the biocompatible cyclotriphosphazene family were prepared, and their in vitro biological activities and effects on circadian rhythm were evaluated for the first time. In particular, new cyclotriphosphazene derivatives carrying morpholine, thiomorpholine and triazole groups were designed and synthesized, and their chemical structures were characterized using appropriate spectroscopic methods. Cellular toxicity analyses of the compounds were performed using different biological methods, such as determination of IC50 values, calculation of population doubling times, and colony formation patterns. Subsequently, the effects of the compounds on the cell cycle were analyzed using the flow cytometry technique. Finally, the effects of the synthesized compounds on circadian rhythm were determined using a real-time bioluminescence approach. Based on these studies, it was determined that some compounds demonstrated varying degrees of antiproliferative activity, with the most potent compounds causing G2/M phase arrest. Additionally, most derivatives had no adverse effects on the circadian rhythm, indicating their potential for safe therapeutic application in targeting cell proliferation. Furthermore, an important pharmacological characteristic of the drug candidate molecules, namely, membrane permeability in terms of log P values, was assessed. In conclusion, these novel cyclotriphosphazene-based compounds are a class of circadian rhythm-safe drug candidate compounds.
- 12 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (5) , 2061-2077
Design, synthesis and in vitro evaluations of new cyclotriphosphazenes as safe drug candidates
Although it is possible to discover new drug candidate molecules using in silico approaches, chemical synthesis followed by screening of their functions is still at the center of bioactive molecule discovery. While determining the potential effects of compounds on target signaling molecules or pathways, assessing their effects on the circadian rhythm is also very important for determining the efficacy of drug candidates because they control most of the signaling pathways. Herein, new members of the biocompatible cyclotriphosphazene family were prepared, and their in vitro biological activities and effects on circadian rhythm were evaluated for the first time. In particular, new cyclotriphosphazene derivatives carrying morpholine, thiomorpholine and triazole groups were designed and synthesized, and their chemical structures were characterized using appropriate spectroscopic methods. Cellular toxicity analyses of the compounds were performed using different biological methods, such as determination of IC50 values, calculation of population doubling times, and colony formation patterns. Subsequently, the effects of the compounds on the cell cycle were analyzed using the flow cytometry technique. Finally, the effects of the synthesized compounds on circadian rhythm were determined using a real-time bioluminescence approach. Based on these studies, it was determined that some compounds demonstrated varying degrees of antiproliferative activity, with the most potent compounds causing G2/M phase arrest. Additionally, most derivatives had no adverse effects on the circadian rhythm, indicating their potential for safe therapeutic application in targeting cell proliferation. Furthermore, an important pharmacological characteristic of the drug candidate molecules, namely, membrane permeability in terms of log P values, was assessed. In conclusion, these novel cyclotriphosphazene-based compounds are a class of circadian rhythm-safe drug candidate compounds.
- Open Access
- 5 February 2024
- Published by Wiley in Photochemistry and Photobiology
- Vol. 100 (5) , 1339-1358
Interactions of drosophila cryptochrome
In this study, we investigate the intricate regulatory mechanisms underlying the circadian clock in Drosophila, focusing on the light‐induced conformational changes in the cryptochrome (DmCry). Upon light exposure, DmCry undergoes conformational changes that prompt its binding to Timeless and Jetlag proteins, initiating a cascade crucial for the starting of a new circadian cycle. DmCry is subsequently degraded, contributing to the desensitization of the resetting mechanism. The transient and short‐lived nature of DmCry protein–protein interactions (PPIs), leading to DmCry degradation within an hour of light exposure, presents a challenge for comprehensive exploration. To address this, we employed proximity‐dependent biotinylation techniques, combining engineered BioID (TurboID) and APEX (APEX2) enzymes with mass spectrometry. This approach enabled the identification of the in vitro DmCry interactome in Drosophila S2 cells, uncovering several novel PPIs associated with DmCry. Validation of these interactions through a novel co‐immunoprecipitation technique enhances the reliability of our findings. Importantly, our study suggests the potential of this method to reveal additional circadian clock‐ or magnetic field‐dependent PPIs involving DmCry. This exploration of the DmCry interactome not only advances our understanding of circadian clock regulation but also establishes a versatile framework for future investigations into light‐ and time‐dependent protein interactions in Drosophila.
- 5 February 2024
- Published by Wiley in Photochemistry and Photobiology
- Vol. 100 (5) , 1339-1358
Open AccessInteractions of drosophila cryptochrome
In this study, we investigate the intricate regulatory mechanisms underlying the circadian clock in Drosophila, focusing on the light‐induced conformational changes in the cryptochrome (DmCry). Upon light exposure, DmCry undergoes conformational changes that prompt its binding to Timeless and Jetlag proteins, initiating a cascade crucial for the starting of a new circadian cycle. DmCry is subsequently degraded, contributing to the desensitization of the resetting mechanism. The transient and short‐lived nature of DmCry protein–protein interactions (PPIs), leading to DmCry degradation within an hour of light exposure, presents a challenge for comprehensive exploration. To address this, we employed proximity‐dependent biotinylation techniques, combining engineered BioID (TurboID) and APEX (APEX2) enzymes with mass spectrometry. This approach enabled the identification of the in vitro DmCry interactome in Drosophila S2 cells, uncovering several novel PPIs associated with DmCry. Validation of these interactions through a novel co‐immunoprecipitation technique enhances the reliability of our findings. Importantly, our study suggests the potential of this method to reveal additional circadian clock‐ or magnetic field‐dependent PPIs involving DmCry. This exploration of the DmCry interactome not only advances our understanding of circadian clock regulation but also establishes a versatile framework for future investigations into light‐ and time‐dependent protein interactions in Drosophila.
- Open Access
- 1 February 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (s1) , 42-60
Invited Speaker Abstracts
Article Invited Speaker Abstracts was published on February 1, 2023 in the journal Turkish Journal of Biochemistry (volume 48, issue s1).
- 1 February 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (s1) , 42-60
Open AccessInvited Speaker Abstracts
Article Invited Speaker Abstracts was published on February 1, 2023 in the journal Turkish Journal of Biochemistry (volume 48, issue s1).
- Open Access
- 8 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice
Cryptochromes are negative transcriptional regulators of the circadian clock in mammals. It is not clear how reducing the level of endogenous CRY1 in mammals will affect circadian rhythm and the relation of such a decrease with apoptosis. Here, we discovered a molecule (M47) that destabilizes Cryptochrome 1 (CRY1) both in vitro and in vivo. The M47 selectively enhanced the degradation rate of CRY1 by increasing its ubiquitination and resulted in increasing the circadian period length of U2OSBmal1-dLuccells. In addition, subcellular fractionation studies from mice liver indicated that M47 increased degradation of the CRY1 in the nucleus. Furthermore, M47-mediated CRY1 reduction enhanced oxaliplatin-induced apoptosis in Ras-transformedp53null fibroblast cells. Systemic repetitive administration of M47 increased the median lifespan ofp53−/−mice by ~25%. Collectively our data suggest that M47 is a promising molecule to treat forms of cancer depending on thep53mutation.
- 8 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessDiscovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice
Cryptochromes are negative transcriptional regulators of the circadian clock in mammals. It is not clear how reducing the level of endogenous CRY1 in mammals will affect circadian rhythm and the relation of such a decrease with apoptosis. Here, we discovered a molecule (M47) that destabilizes Cryptochrome 1 (CRY1) both in vitro and in vivo. The M47 selectively enhanced the degradation rate of CRY1 by increasing its ubiquitination and resulted in increasing the circadian period length of U2OSBmal1-dLuccells. In addition, subcellular fractionation studies from mice liver indicated that M47 increased degradation of the CRY1 in the nucleus. Furthermore, M47-mediated CRY1 reduction enhanced oxaliplatin-induced apoptosis in Ras-transformedp53null fibroblast cells. Systemic repetitive administration of M47 increased the median lifespan ofp53−/−mice by ~25%. Collectively our data suggest that M47 is a promising molecule to treat forms of cancer depending on thep53mutation.
- 4 February 2022
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 90 (6) , 1315-1330
Proteome analysis of the circadian clock protein PERIOD2
Circadian rhythms are a series of endogenous autonomous 24‐h oscillations generated by the circadian clock. At the molecular level, the circadian clock is based on a transcription–translation feedback loop, in which BMAL1 and CLOCK transcription factors of the positive arm activate the expression of CRYPTOCHROME (CRY) and PERIOD (PER) genes of the negative arm as well as the circadian clock‐regulated genes. There are three PER proteins, of which PER2 shows the strongest oscillation at both stability and cellular localization level. Protein–protein interactions (PPIs) or interactome of the circadian clock proteins have been investigated using classical methods such as two‐dimensional gel electrophoresis, immunoprecipitation‐coupled mass spectrometry, and yeast‐two hybrid assay where the dynamic and weak interactions are difficult to catch. To identify the interactome of PER2 we have adopted proximity‐dependent labeling with biotin and mass spectrometry‐based identification of labeled proteins (BioID). In addition to known interactions with such as CRY1 and CRY2, we have identified several new PPIs for PER2 and confirmed some of them using co‐immunoprecipitation technique. This study characterizes the PER2 protein interactions in depth, and it also implies that using a fast BioID method with miniTurbo or TurboID coupled to other major circadian clock proteins might uncover other interactors in the clock that have yet to be discovered.
- 4 February 2022
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 90 (6) , 1315-1330
Proteome analysis of the circadian clock protein PERIOD2
Circadian rhythms are a series of endogenous autonomous 24‐h oscillations generated by the circadian clock. At the molecular level, the circadian clock is based on a transcription–translation feedback loop, in which BMAL1 and CLOCK transcription factors of the positive arm activate the expression of CRYPTOCHROME (CRY) and PERIOD (PER) genes of the negative arm as well as the circadian clock‐regulated genes. There are three PER proteins, of which PER2 shows the strongest oscillation at both stability and cellular localization level. Protein–protein interactions (PPIs) or interactome of the circadian clock proteins have been investigated using classical methods such as two‐dimensional gel electrophoresis, immunoprecipitation‐coupled mass spectrometry, and yeast‐two hybrid assay where the dynamic and weak interactions are difficult to catch. To identify the interactome of PER2 we have adopted proximity‐dependent labeling with biotin and mass spectrometry‐based identification of labeled proteins (BioID). In addition to known interactions with such as CRY1 and CRY2, we have identified several new PPIs for PER2 and confirmed some of them using co‐immunoprecipitation technique. This study characterizes the PER2 protein interactions in depth, and it also implies that using a fast BioID method with miniTurbo or TurboID coupled to other major circadian clock proteins might uncover other interactors in the clock that have yet to be discovered.
- Open Access
- 9 November 2021
- Published by Wiley in The FEBS Journal
- Vol. 289 (21) , 6622-6639
Light‐dependent reactions of animal circadian photoreceptor cryptochrome
Circadian rhythms are endogenous autonomous 24‐h oscillations that are generated by a transcription–translation feedback loop (TTFL). In the positive arm of the TTFL, two transcription factors activate the expression of two genes of the negative arm as well as circadian clock‐regulated genes. The circadian clocks are reset through photoreceptor proteins by sunlight in the early morning to keep synchrony with the geological clock. Among animal circadian photoreceptors, Drosophila Cryptochrome (DmCRY) has some unique properties because Drosophila has a single cryptochrome (CRY) that appears to have functions which are specific to organs or tissues, or even to a subset of cells. In mammals, CRYs are not photoreceptors but function in the TTFL, while insects have a light‐insensitive mammalian‐like CRY or a Drosophila‐like photoreceptor CRY (or both). Here, we postulate that as being just one CRY in Drosophila, DmCRY might play different roles in different tissues/organs in a context‐dependent manner. In addition to being a circadian photoreceptor/protein, attributing also a magnetoreception function to DmCRY has increased its workload. Considering that DmCRY senses photons as a photoreceptor but also can regulate many different events in a light‐dependent manner, differential protein–protein interactions (PPIs) of DmCRY might play a critical role in the generation of such diverse outputs. Therefore, we need to add novel approaches in addition to the current ones to study multiple and context‐dependent functions of DmCRY by adopting recently developed techniques. Successful identification of transient/fast PPIs on a scale of minutes would enhance our understanding of light‐dependent and/or magnetoreception‐associated reactions.
- 9 November 2021
- Published by Wiley in The FEBS Journal
- Vol. 289 (21) , 6622-6639
Open AccessLight‐dependent reactions of animal circadian photoreceptor cryptochrome
Circadian rhythms are endogenous autonomous 24‐h oscillations that are generated by a transcription–translation feedback loop (TTFL). In the positive arm of the TTFL, two transcription factors activate the expression of two genes of the negative arm as well as circadian clock‐regulated genes. The circadian clocks are reset through photoreceptor proteins by sunlight in the early morning to keep synchrony with the geological clock. Among animal circadian photoreceptors, Drosophila Cryptochrome (DmCRY) has some unique properties because Drosophila has a single cryptochrome (CRY) that appears to have functions which are specific to organs or tissues, or even to a subset of cells. In mammals, CRYs are not photoreceptors but function in the TTFL, while insects have a light‐insensitive mammalian‐like CRY or a Drosophila‐like photoreceptor CRY (or both). Here, we postulate that as being just one CRY in Drosophila, DmCRY might play different roles in different tissues/organs in a context‐dependent manner. In addition to being a circadian photoreceptor/protein, attributing also a magnetoreception function to DmCRY has increased its workload. Considering that DmCRY senses photons as a photoreceptor but also can regulate many different events in a light‐dependent manner, differential protein–protein interactions (PPIs) of DmCRY might play a critical role in the generation of such diverse outputs. Therefore, we need to add novel approaches in addition to the current ones to study multiple and context‐dependent functions of DmCRY by adopting recently developed techniques. Successful identification of transient/fast PPIs on a scale of minutes would enhance our understanding of light‐dependent and/or magnetoreception‐associated reactions.
- 27 October 2020
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 21 (1) , 1-16
Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects
We have previously reported that the deletion of BMAL1 gene has opposite effects in respect to its contribution to the pathways that are effective in the multistage carcinogenesis process. BMAL1 deletion sensitized nearly normal breast epithelial (MCF10A) and invasive breast cancer cells (MDA-MB-231) to cisplatin- and doxorubicin-induced apoptosis, while this deletion also aggravated the invasive potential of MDA-MB-231 cells. However, the mechanistic relationship of the seemingly opposite contribution of BMAL1 deletion to carcinogenesis process is not known at genome-wide level. In this study, an RNA-seq approach was taken to uncover the differentially expressed genes (DEGs) and pathways after treating BMAL1 knockout (KO) or wild-type (WT) MDA-MB-231 cells with cisplatin and doxorubicin to initiate apoptosis. Gene set enrichment analysis with the DEGs demonstrated that enrichment in multiple genes/pathways contributes to sensitization to cisplatin- or doxorubicin-induced apoptosis in BMAL1-dependent manner. Additionally, our DEG analysis suggested that non-coding transcript RNA (such as lncRNA and processed pseudogenes) may have role in cisplatin- or doxorubicin-induced apoptosis. Protein-protein interaction network obtained from common DEGs in cisplatin and doxorubicin treatments revealed that GSK3β, NACC1, and EGFR are the principal genes regulating the response of the KO cells. Moreover, the analysis of DEGs among untreated BMAL1 KO and WT cells revealed that epithelial-mesenchymal transition genes are up-regulated in KO cells. As a negative control, we have also analyzed the DEGs following treatment with an endoplasmic reticulum (ER) stress-inducing agent, tunicamycin, which was affected by BMAL1 deletion minimally. Collectively, the present study suggests that BMAL1 regulates many genes/pathways of which the alteration in BMAL1 KO cells may shed light on pleotropic phenotype observed.
- 27 October 2020
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 21 (1) , 1-16
Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects
We have previously reported that the deletion of BMAL1 gene has opposite effects in respect to its contribution to the pathways that are effective in the multistage carcinogenesis process. BMAL1 deletion sensitized nearly normal breast epithelial (MCF10A) and invasive breast cancer cells (MDA-MB-231) to cisplatin- and doxorubicin-induced apoptosis, while this deletion also aggravated the invasive potential of MDA-MB-231 cells. However, the mechanistic relationship of the seemingly opposite contribution of BMAL1 deletion to carcinogenesis process is not known at genome-wide level. In this study, an RNA-seq approach was taken to uncover the differentially expressed genes (DEGs) and pathways after treating BMAL1 knockout (KO) or wild-type (WT) MDA-MB-231 cells with cisplatin and doxorubicin to initiate apoptosis. Gene set enrichment analysis with the DEGs demonstrated that enrichment in multiple genes/pathways contributes to sensitization to cisplatin- or doxorubicin-induced apoptosis in BMAL1-dependent manner. Additionally, our DEG analysis suggested that non-coding transcript RNA (such as lncRNA and processed pseudogenes) may have role in cisplatin- or doxorubicin-induced apoptosis. Protein-protein interaction network obtained from common DEGs in cisplatin and doxorubicin treatments revealed that GSK3β, NACC1, and EGFR are the principal genes regulating the response of the KO cells. Moreover, the analysis of DEGs among untreated BMAL1 KO and WT cells revealed that epithelial-mesenchymal transition genes are up-regulated in KO cells. As a negative control, we have also analyzed the DEGs following treatment with an endoplasmic reticulum (ER) stress-inducing agent, tunicamycin, which was affected by BMAL1 deletion minimally. Collectively, the present study suggests that BMAL1 regulates many genes/pathways of which the alteration in BMAL1 KO cells may shed light on pleotropic phenotype observed.
- Open Access
- 1 March 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (11) , 3518-3531
A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude
- 1 March 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (11) , 3518-3531
Open AccessA CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude
- 3 October 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (43) , 4352-4360
Identification and Characterization of a New Class of (6–4) Photolyase from Vibrio cholerae
Light is crucial for most of the organisms to perform many biological activities including vision, resetting of circadian rhythm, photosynthesis, and DNA repair. The Cryptochrome/Photolyase Family (CPF) represents an ancient group of UV-A/blue-light sensitive proteins performing different functions such as DNA repair, circadian photoreception, and transcriptional regulation. The CPF is widely distributed throughout all organisms including marine (aquatic) prokaryotes. Bacterium Vibrio cholerae was previously shown to have a CPD photolyase repairing UV-induced thymine dimers; and two CRY-DASHs that repair UV-induced single-stranded DNA damages. Here we characterized a hypothetical gene Vca0809 encoding a new member of photolyase family in this organism. The spectroscopic analysis of the purified protein indicated that this enzyme possessed catalytic cofactor, FAD, and photoantenna chromophore 6,7-dimethyl 8-ribityl-lumazin. With a slot blot-based DNA repair assay, we showed that it possessed (6-4) photolyase activity. Further phylogenetic and computational analyses enabled us to classify this gene as a member of iron-sulfur bacterial cryptochromes and photolyases (FeS-BCP). Therefore, we named this gene as Vc(6-4) FeS-BCP.
- 3 October 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (43) , 4352-4360
Identification and Characterization of a New Class of (6–4) Photolyase from Vibrio cholerae
Light is crucial for most of the organisms to perform many biological activities including vision, resetting of circadian rhythm, photosynthesis, and DNA repair. The Cryptochrome/Photolyase Family (CPF) represents an ancient group of UV-A/blue-light sensitive proteins performing different functions such as DNA repair, circadian photoreception, and transcriptional regulation. The CPF is widely distributed throughout all organisms including marine (aquatic) prokaryotes. Bacterium Vibrio cholerae was previously shown to have a CPD photolyase repairing UV-induced thymine dimers; and two CRY-DASHs that repair UV-induced single-stranded DNA damages. Here we characterized a hypothetical gene Vca0809 encoding a new member of photolyase family in this organism. The spectroscopic analysis of the purified protein indicated that this enzyme possessed catalytic cofactor, FAD, and photoantenna chromophore 6,7-dimethyl 8-ribityl-lumazin. With a slot blot-based DNA repair assay, we showed that it possessed (6-4) photolyase activity. Further phylogenetic and computational analyses enabled us to classify this gene as a member of iron-sulfur bacterial cryptochromes and photolyases (FeS-BCP). Therefore, we named this gene as Vc(6-4) FeS-BCP.